Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell surface components and virulence-associated enzymes represent a broad category of molecular structures and catalytic proteins essential for the survival and pathogenicity of infectious agents. Surface components, such as the bacterial peptidoglycan layer, fungal ergosterol, and viral envelope glycoproteins, provide structural stability and facilitate the initial attachment of pathogens to host tissues (NIH, 2023). Virulence-associated enzymes, including proteases, phospholipases, and neuraminidases, are employed by microbes to degrade host barriers, acquire nutrients, and evade immune detection (StatPearls, 2023). These molecules are the primary focus of antimicrobial drug development, as they often possess unique structural features not found in human cells, allowing for selective toxicity. For instance, beta-lactam antibiotics target penicillin-binding proteins involved in cell wall synthesis, while neuraminidase inhibitors prevent the release of viral progeny from infected cells (PubMed, 2022). However, the high mutation rates of these targets contribute significantly to the global challenge of antimicrobial resistance.
Inhibition of cell wall biosynthesis, disruption of cell membrane integrity, or competitive inhibition of enzymes required for pathogen replication and host tissue degradation (PubMed, 2021).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell surface components and virulence-associated enzymes.